Cargando…

Body Weight Gain and Hyperphagia After Administration of SGLT-2 Inhibitor: A Case Report

Patient: Male, 44 Final Diagnosis: Type 2 diabetes Symptoms: Hunger • increased appetite Medication: GLP-1 receptor agonist • SGLT-2 inhibitor Clinical Procedure: — Specialty: Internal Medicine/Diabetology OBJECTIVE: Unusual or unexpected effect of treatment BACKGROUND: A detailed description is giv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hamamoto, Hiromi, Noda, Mitsuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675553/ https://www.ncbi.nlm.nih.gov/pubmed/26638727 http://dx.doi.org/10.12659/AJCR.896233

Ejemplares similares

Analyzing the Factors Contributing to Withdrawal from Insulin Therapy Following Additional Administration of Alogliptin: Retrospective Study after Removing Glucotoxicity with Insulin
por: Hamamoto, Hiromi, et al.
Publicado: (2015)

Blunted Vagal Cocaine- and Amphetamine-Regulated Transcript Promotes Hyperphagia and Weight Gain
por: Lee, Shin J., et al.
Publicado: (2020)

Hyperinsulinemia is a probable trigger for weight gain and hyperphagia in individuals with Prader‐Willi syndrome
por: Kweh, Frederick A., et al.
Publicado: (2023)

Olanzapine-Induced Hyperphagia and Weight Gain Associate with Orexigenic Hypothalamic Neuropeptide Signaling without Concomitant AMPK Phosphorylation
por: Fernø, Johan, et al.
Publicado: (2011)

Intact vagal gut‐brain signalling prevents hyperphagia and excessive weight gain in response to high‐fat high‐sugar diet
por: McDougle, Molly, et al.
Publicado: (2020)

Food Intake and Hypothalamic Hyperphagia
por: Strominger, Jack L., et al.
Publicado: (1953)

Massive obesity and hyperphagia in posterior bilateral periventricular heterotopias: case report
por: Guglielmi, Valeria, et al.
Publicado: (2016)

Fasting inhibits excitatory synaptic input on paraventricular oxytocin neurons via neuropeptide Y and Y1 receptor, inducing rebound hyperphagia, and weight gain
por: Wang, Lei, et al.
Publicado: (2022)

Experimental Hypothalamic Hyperphagia in the Albino Rat
por: Brobeck, John R., et al.
Publicado: (1943)

Efficacy of Body Weight Reduction on the SGLT2 Inhibitor in People with Type 2 Diabetes Mellitus
por: Cho, Hyun A, et al.
Publicado: (2017)

Hyperphagia, Growth, and Puberty in Children with Angelman Syndrome
por: Bindels-de Heus, Karen G. C. B., et al.
Publicado: (2023)

Gastric Expression of Plasminogen Activator Inhibitor (PAI)-1 Is Associated with Hyperphagia and Obesity in Mice
por: Kenny, Susan, et al.
Publicado: (2013)

SGLT-2 inhibitors and atrial fibrillation in the Food and Drug Administration adverse event reporting system
por: Bonora, Benedetta Maria, et al.
Publicado: (2021)

Hypermetabolism, Hyperphagia, and Reduced Adiposity in Tankyrase-Deficient Mice
por: Yeh, Tsung-Yin J., et al.
Publicado: (2009)

Myostatin inhibition improves hyperglycemia and hyperphagia in lipodystrophic mice
por: Guo, Tingqing, et al.
Publicado: (2012)

Hemiballismus, Hyperphagia, and Behavioral Changes following Subthalamic Infarct
por: Etemadifar, Masoud, et al.
Publicado: (2012)

Behavioral Characterization of the Hyperphagia Synphilin-1 Overexpressing Mice
por: Li, Xueping, et al.
Publicado: (2014)

Adipocyte OGT governs diet-induced hyperphagia and obesity
por: Li, Min-Dian, et al.
Publicado: (2018)

Stress-induced hyperphagia: empirical characterization of stress-overeaters
por: Kaiser, Birgit, et al.
Publicado: (2022)

Hematocrit elevation after SGLT2 inhibitor administration may be associated with the degree of proximal tubular damage
por: Shikuma, Jumpei, et al.
Publicado: (2022)

Thresholds for optimal fluid administration and weight gain after laparoscopic colorectal surgery
por: Hübner, M., et al.
Publicado: (2019)

Falls and SGLT-2 inhibitors in geriatric patients—A case report
por: Taşdemir, Anil, et al.
Publicado: (2020)

Involvement of inflammatory gene expression pathways in depressed patients with hyperphagia
por: de Kluiver, Hilde, et al.
Publicado: (2019)

Licogliflozin, a Novel SGLT1 and 2 Inhibitor: Body Weight Effects in a Randomized Trial in Adults with Overweight or Obesity
por: Bays, Harold E., et al.
Publicado: (2020)

Assessment of residual body weight gain and residual intake and body weight gain as feed efficiency traits in the turkey (Meleagris gallopavo)
por: Willems, Owen W, et al.
Publicado: (2013)

SGLT2 Inhibitor–Induced Euglycemic Diabetic Ketoacidosis: A Case Report
por: Wang, Katherine M., et al.
Publicado: (2020)

Medication Trials for Hyperphagia and Food-Related Behaviors in Prader–Willi Syndrome
por: Miller, Jennifer L., et al.
Publicado: (2015)

THE EFFECT OF HYPERGLYCEMIA ON HYPOTHALAMIC GOLD UPTAKE AND HYPERPHAGIA IN GOLDTHIOGLUCOSE-TREATED MICE
por: Edelman, P. Michael, et al.
Publicado: (1965)

The Effects of Hypothalamic Hyperphagia and of Alterations in Feeding Habits on the Metabolism of the Albino Rat
por: Tepperman, Jay, et al.
Publicado: (1943)

Myostatin Inhibition Prevents Diabetes and Hyperphagia in a Mouse Model of Lipodystrophy
por: Guo, Tingqing, et al.
Publicado: (2012)

Deletion of leptin signaling in vagal afferent neurons results in hyperphagia and obesity
por: de Lartigue, Guillaume, et al.
Publicado: (2014)

Elevated Hypothalamic Glucocorticoid Levels Are Associated With Obesity and Hyperphagia in Male Mice
por: Sefton, Charlotte, et al.
Publicado: (2016)

Hypothalamic loss of Snord116 recapitulates the hyperphagia of Prader-Willi syndrome
por: Polex-Wolf, Joseph, et al.
Publicado: (2018)

Hyperphagia and Obesity in Prader–Willi Syndrome: PCSK1 Deficiency and Beyond?
por: Ramos-Molina, Bruno, et al.
Publicado: (2018)

Heart rate during hyperphagia differs between two bear species
por: Fuchs, Boris, et al.
Publicado: (2019)

A critical role of hepatic GABA in the metabolic dysfunction and hyperphagia of obesity
por: Geisler, Caroline E., et al.
Publicado: (2021)

Cold-induced hyperphagia requires AgRP neuron activation in mice
por: Deem, Jennifer D, et al.
Publicado: (2020)

Obesity and Hyperphagia With Increased Defective ACTH: A Novel POMC Variant
por: van der Valk, Eline S, et al.
Publicado: (2022)

Development and validation of the Pediatric-Youth Hyperphagia Assessment for Prader-Willi syndrome
por: Cho, Sung Yoon, et al.
Publicado: (2022)

Burden of hyperphagia and obesity in Bardet–Biedl syndrome: a multicountry survey
por: Forsythe, Elizabeth, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_69aqmnr5ibg1h63dd1423ersat